has lost $88billion in market share and $144billion in value since its market peak in just one year as the drugmaker suffers a major hangover from the success of its COVID vaccine.The pharmaceutical giant enjoyed a record $100billion in sales last year, powered by its COVID vaccine and drug.But after becoming the first pharma firm to break the billion-dollar barrier, its performance has fallen off a cliff this year.
Load More
Load More